Excellent
Tesamorelin
Tesamorelin is a growth hormone-releasing peptide that reduces visceral fat while supporting metabolic health and body composition.
Reduces stubborn belly fat
Improves body composition
Enhances metabolism
Supports lean muscle preservation
* Price reflects a 6-month treatment plan. For research purposes only.
How It Works
Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) that stimulates the pituitary gland to increase natural growth hormone production. This boost in GH elevates IGF-1 levels, enhancing fat metabolism, protein synthesis, and cellular repair. The result is a targeted reduction in abdominal fat and improvements in overall metabolic balance — making it a compelling option for those looking to buy Tesamorelin for body composition and metabolic support.
Discovery & Testing Background
Tesamorelin was developed in the early 2000s by Theratechnologies and gained FDA approval in 2010 for the treatment of HIV-associated lipodystrophy. Clinical trials demonstrated significant reductions in visceral adipose tissue, improved lipid profiles, and favorable effects on body composition. Research has since expanded into broader metabolic applications, including obesity and age-related fat redistribution, with ongoing studies evaluating its potential beyond its original indication.
Potential Side Effects
Commonly reported side effects include mild injection site reactions, joint discomfort, or fluid retention. In rare cases, increased blood sugar levels or carpal tunnel symptoms have been observed.
Tesamorelin Peptide Benefits
Function: Tesamorelin is studied for its possible role in stimulating physiological growth hormone and IGF-1 secretion through GHRH receptor activation, with targeted effects on visceral fat metabolism and lean body composition in preclinical and clinical research.
Benefit: This research has drawn attention for its potential support in visceral fat reduction, protein synthesis, metabolic balance, and cellular repair through a natural GH axis stimulation approach. That is why many high-performers look to buy Tesamorelin through a clinician-led program that explains use, quality, and safety clearly.
See the Science
Effects of Tesamorelin on Non-Alcoholic Fatty Liver Disease in HIV: A Randomised, Double-Blind, Multicentre Trial2019
Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV2014
Pooled Phase-3 Analysis of Tesamorelin in ART-Treated HIV With Excess Abdominal Fat2010
Reduction in Visceral Adiposity Is Associated With Improved Metabolic Risk in Tesamorelin Phase-3 Trials2012
Long-Term Safety and Durability of Tesamorelin in HIV-Associated Abdominal Fat Accumulation2008
Key Takeaways
Targeted Visceral Fat Reduction
Metabolic Health Support
Muscle-Preserving Growth Hormone Boost
Safe & Well-Tolerated
Frequently asked questions
Is Tesamorelin FDA-approved?
Tesamorelin is FDA-approved to reduce excess abdominal visceral fat in adults with HIV-associated lipodystrophy.
Has it been tested in humans?
Yes, multiple randomized trials show meaningful VAT reduction, improved lipid profiles, and neutral overall body weight.
What does it appear to do?
Tesamorelin stimulates your own GH/IGF-1 axis, which helps target deep belly fat and improve metabolic markers like triglycerides without acting as a stimulant or appetite suppressant.
Is it safe?
Tesamorelin is generally well tolerated in studies. The most common effects are injection-site reactions, fluid retention/edema, joint aches, and transient changes in glucose/IGF-1.
Who should avoid it?
People who are pregnant or nursing, have active cancer, pituitary tumors/disorders, uncontrolled diabetes, or a known hypersensitivity to Tesamorelin should not use it. Use should always be overseen by a clinician.
How is it typically administered?
A once-daily subcutaneous injection, usually in the abdomen, with sites rotated. Providers monitor IGF-1 and glucose to keep therapy on target.
Can it be combined with other peptides or therapies?
Yes, Tesamorelin is often paired with complementary peptides to support body-composition goals. It is commonly combined with AOD-9604 for additional fat-metabolism support, and MOTS-C or NAD+ for improved energy utilization and metabolic efficiency. Some patients also stack Tesamorelin with BPC-157 or BPC-157 + TB-500 when recovery or soft-tissue repair is a priority. For patients seeking enhanced growth hormone signaling alongside Tesamorelin, AIRA offers a dedicated Tesamorelin + Ipamorelin protocol. Any stack should be clinician-supervised.
Related Treatments
How AIRA works
Medical intake via telehealth
Prescription by licensed providers
Fast, discreet delivery
Why AIRA? Trusted peptides online
Your body already holds the blueprint — AIRA helps you unlock it. Our physician-guided peptide programs will help you perform, recover, and feel your best.
Chat with a provider 24/7
Trusted pharmacy
Manage goals in one place
Fast, discreet shipping
Start your new AIRA today
Unleash a healthier, more energetic version of yourself with AIRA. Check out treatments now and embark on your journey to a fulfilling life.
